Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Encapsulated hemoglobin: current issues and future goals

A S Rudolph1

  • 1Center for Biomolecular Science and Engineering, Naval Research Laboratory, Washington, DC 20375-5348.

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell and tissue based technologies for environmental detection and medical diagnostics.

Biosensors & bioelectronics·2001
Same author

Direct measurements of hemoglobin interactions with liposomes using EPR spectroscopy.

Artificial cells, blood substitutes, and immobilization biotechnology·2001
Same author

Effects of free and liposome-encapsulated hemoglobin on choroidal vascular plexus blood flow, using the rabbit eye as a model system.

European journal of ophthalmology·1999
Same author

Electrical, chemical, and topological addressing of mammalian cells with microfabricated systems.

Journal of biomechanical engineering·1999
Same author

Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.

The Journal of pharmacology and experimental therapeutics·1999
Same author

Use of oxygen-15-labeled molecular oxygen for oxygen delivery studies of blood and blood substitutes.

Advances in experimental medicine and biology·1999
Same journal

The effect of polymerized placenta hemoglobin on renal ischemia/reperfusion injury.

Artificial cells, blood substitutes, and immobilization biotechnology·2012
Same journal

Immune-stimulating potential of cell envelope proteins from Vibrio cholerae associated to chitosan microparticles: an in vitro study.

Artificial cells, blood substitutes, and immobilization biotechnology·2012
Same journal

Immobilization of anti-aflatoxin B1 antibody by UV polymerization of aniline and aflatoxin B1 detection via electrochemical impedance spectroscopy.

Artificial cells, blood substitutes, and immobilization biotechnology·2012
Same journal

Purification and characterization of prophenoloxidase from Galleria mellonella L.

Artificial cells, blood substitutes, and immobilization biotechnology·2012
Same journal

Chitosan-based intragastric delivery of cefuroxime axetil: development and in-vitro evaluation of mucoadhesive approach.

Artificial cells, blood substitutes, and immobilization biotechnology·2012
Same journal

In vitro effect of novel β-lactam compounds on xanthine oxidase enzyme activity.

Artificial cells, blood substitutes, and immobilization biotechnology·2012
See all related articles

Liposome encapsulation of hemoglobin mimics natural circulation, reducing toxicity and extending persistence. This approach shows promise for artificial oxygen carriers, though further research is needed for large-scale production and safety.

Area of Science:

  • Biomedical Engineering
  • Drug Delivery Systems
  • Hematology

Background:

  • Encapsulation systems aim to mimic natural hemoglobin circulation, reduce toxicity, and improve persistence.
  • Liposomes, biodegradable and biocompatible phospholipid vesicles, are a key vehicle for hemoglobin encapsulation.
  • Previous research focused on liposome-encapsulated hemoglobin (LEH) in various animal models.

Purpose of the Study:

  • To evaluate the efficacy and safety of liposome-encapsulated hemoglobin (LEH).
  • To understand LEH's circulation persistence, biodistribution, and effects on physiological parameters.
  • To address challenges in large-scale production for commercial development.

Main Methods:

  • Demonstration of efficacy and safety in isovolemic and hypovolemic exchange models.

Related Experiment Videos

  • Assessment of hemodynamics, circulation persistence, and organ biodistribution in small animals.
  • Evaluation of processing methods, long-term storage (freeze-drying), serum changes, and histopathology.

    • Main Results:

    • LEH significantly alters effects compared to cell-free hemoglobin solutions.
    • LEH circulates for 20-24 hours in small animals, primarily distributing to the liver and spleen.
    • Transient hemodynamic and serum changes observed, often related to liposome characteristics.

    Conclusions:

    • Encapsulation of hemoglobin, particularly in liposomes, offers a promising strategy for artificial oxygen carriers.
    • Further investigation into reticuloendothelial system and macrophage function is required due to organ accumulation.
    • Optimization of encapsulation efficiency and particle size distribution is crucial for commercialization.